Insights

Expanding Market Presence Exothera is actively expanding into North America with a new facility in Massachusetts and recent client acquisitions like the NIH and Asgard Therapeutics, presenting opportunities to introduce complementary clinical and commercial manufacturing solutions.

Innovative Platform Launch The launch of Exothera's mRNA Ntensify platform indicates a focus on nucleic acid therapeutics, creating potential sales avenues within companies developing mRNA vaccines and personalized gene therapies.

Strategic Collaborations Partnerships with IDT Biologika and high-profile clients like NIH demonstrate a strong track record in viral vector manufacturing, positioning Exothera as a preferred CDMO for organizations advancing gene therapy and vaccine projects.

Robust Growth Signals With revenue estimates between 50 to 100 million dollars and rapid client onboarding, Exothera offers substantial growth potential to investors and partners seeking scalable bioprocessing solutions.

Focus on Viral Vector Innovation Specializing in viral vector and nucleic acid production with advanced manufacturing technologies, Exothera is well-positioned to serve emerging market needs in gene therapy, vaccine development, and personalized medicine sectors.

Exothera Tech Stack

Exothera uses 8 technology products and services including Google Ads, Microsoft Clarity, oEmbed, and more. Explore Exothera's tech stack below.

  • Google Ads
    Advertising
  • Microsoft Clarity
    Analytics
  • oEmbed
    Dev Tools
  • JSON-LD
    Javascript Frameworks
  • Divi
    Page Builders
  • Priority Hints
    Performance
  • X-XSS-Protection
    Security
  • Google Analytics
    Web Analytics

Media & News

Exothera's Email Address Formats

Exothera uses at least 1 format(s):
Exothera Email FormatsExamplePercentage
F.Last@exothera.worldJ.Doe@exothera.world
49%
First@exothera.worldJohn@exothera.world
1%
F.Last@exothera.worldJ.Doe@exothera.world
49%
First@exothera.worldJohn@exothera.world
1%

Frequently Asked Questions

What is Exothera's official website and social media links?

Minus sign iconPlus sign icon
Exothera's official website is exothera.world and has social profiles on LinkedIn.

What is Exothera's SIC code NAICS code?

Minus sign iconPlus sign icon
Exothera's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Exothera have currently?

Minus sign iconPlus sign icon
As of December 2025, Exothera has approximately 201 employees across 1 continents, including Europe. Key team members include Chief Technology Officer: H. P. L.Head Of Quality (qa/Qc), Qualified Person: V. D.Head Of E2e Solutions: B. D.. Explore Exothera's employee directory with LeadIQ.

What industry does Exothera belong to?

Minus sign iconPlus sign icon
Exothera operates in the Biotechnology Research industry.

What technology does Exothera use?

Minus sign iconPlus sign icon
Exothera's tech stack includes Google AdsMicrosoft ClarityoEmbedJSON-LDDiviPriority HintsX-XSS-ProtectionGoogle Analytics.

What is Exothera's email format?

Minus sign iconPlus sign icon
Exothera's email format typically follows the pattern of F.Last@exothera.world. Find more Exothera email formats with LeadIQ.

Exothera

Biotechnology ResearchWallonia, Belgium201-500 Employees

Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all.

As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing.

Company number: 0744643660 
VAT: BE0744643660

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
201-500

Section iconFunding & Financials

  • $50M$100M

    Exothera's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    Exothera's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.